[1]
“Successful Treatment of Posttransplant Recurrent Complement C3 Glomerulopathy with Eculizumab”, IJKD, vol. 12, no. 5, pp. 315–318, Oct. 2018, Accessed: Dec. 22, 2024. [Online]. Available: https://ijkd.org/index.php/ijkd/article/view/3806